Search research articles
Contact Us
Filters
Showing results (121-130 of 525) with videos related to
Page
of 53
Sort By:
The Lancet. Digital Health
|
October 1, 2022
Radiomics in neuro-oncological clinical trials
Philipp Lohmann, Enrico Franceschi, Philipp Vollmuth, et al.
Annals of Neurology
|
July 26, 2011
Current concepts and management of glioblastoma
Matthias Preusser, Sandrine de Ribaupierre, Adelheid Wöhrer, et al.
Clinical Neuropathology
|
January 28, 2017
Validation of nuclear STAT6 immunostaining as a diagnostic marker of meningeal solitary fibrous tumor (SFT)/hemangiopericytoma
Anna S Berghoff, Philip Kresl, Michal Bienkowski, et al.
Radiology and Oncology
|
August 31, 2012
Frequent MGMT (0(6)-methylguanine-DNA methyltransferase) hypermethylation in long-term survivors of glioblastoma: a single institution experience
Martina Baur, Matthias Preusser, Maria Piribauer, et al.
International Journal of Oncology
|
January 12, 2024
Targeting endogenous fatty acid synthesis stimulates the migration of ovarian cancer cells to adipocytes and promotes the transport of fatty acids from adipocytes to cancer cells
Thomas W Grunt, Renate Wagner, Alexander Ries, et al.
International Journal of Molecular Sciences
|
December 23, 2022
Antithrombin Activity and Association with Risk of Thrombosis and Mortality in Patients with Cancer
Cornelia Englisch, Oliver Königsbrügge, Stephan Nopp, et al.
Plos One
|
July 18, 2013
NRAS and BRAF mutations in melanoma-associated nevi and uninvolved nevi
Philipp Tschandl, Anna Sophie Berghoff, Matthias Preusser, et al.
Cancer Investigation
|
May 8, 2015
microRNA-21 expression is elevated in esophageal adenocarcinoma after neoadjuvant chemotherapy
Aysegül Ilhan-Mutlu, Gülcin Tezcan, Sebastian F Schoppmann, et al.
Nature Reviews. Neurology
|
May 13, 2017
Vaccine-based immunotherapeutic approaches to gliomas and beyond
Michael Weller, Patrick Roth, Matthias Preusser, et al.
JAMA Oncology
|
September 22, 2022
Inhibition of SARS-CoV-2 Omicron BA.1 and BA.4 Variants After Fourth Vaccination or Tixagevimab and Cilgavimab Administration in Patients With Cancer
Maximilian J Mair, Manfred Mitterer, Pia Gattinger, et al.
Page
of 53
Search research articles
Search
Showing results (121-130 of 525) with videos related to
Sort By:
Page
of 53
The Lancet. Digital Health
|
October 1, 2022
Radiomics in neuro-oncological clinical trials
Philipp Lohmann, Enrico Franceschi, Philipp Vollmuth, et al.
Annals of Neurology
|
July 26, 2011
Current concepts and management of glioblastoma
Matthias Preusser, Sandrine de Ribaupierre, Adelheid Wöhrer, et al.
Clinical Neuropathology
|
January 28, 2017
Validation of nuclear STAT6 immunostaining as a diagnostic marker of meningeal solitary fibrous tumor (SFT)/hemangiopericytoma
Anna S Berghoff, Philip Kresl, Michal Bienkowski, et al.
Radiology and Oncology
|
August 31, 2012
Frequent MGMT (0(6)-methylguanine-DNA methyltransferase) hypermethylation in long-term survivors of glioblastoma: a single institution experience
Martina Baur, Matthias Preusser, Maria Piribauer, et al.
International Journal of Oncology
|
January 12, 2024
Targeting endogenous fatty acid synthesis stimulates the migration of ovarian cancer cells to adipocytes and promotes the transport of fatty acids from adipocytes to cancer cells
Thomas W Grunt, Renate Wagner, Alexander Ries, et al.
International Journal of Molecular Sciences
|
December 23, 2022
Antithrombin Activity and Association with Risk of Thrombosis and Mortality in Patients with Cancer
Cornelia Englisch, Oliver Königsbrügge, Stephan Nopp, et al.
Plos One
|
July 18, 2013
NRAS and BRAF mutations in melanoma-associated nevi and uninvolved nevi
Philipp Tschandl, Anna Sophie Berghoff, Matthias Preusser, et al.
Cancer Investigation
|
May 8, 2015
microRNA-21 expression is elevated in esophageal adenocarcinoma after neoadjuvant chemotherapy
Aysegül Ilhan-Mutlu, Gülcin Tezcan, Sebastian F Schoppmann, et al.
Nature Reviews. Neurology
|
May 13, 2017
Vaccine-based immunotherapeutic approaches to gliomas and beyond
Michael Weller, Patrick Roth, Matthias Preusser, et al.
JAMA Oncology
|
September 22, 2022
Inhibition of SARS-CoV-2 Omicron BA.1 and BA.4 Variants After Fourth Vaccination or Tixagevimab and Cilgavimab Administration in Patients With Cancer
Maximilian J Mair, Manfred Mitterer, Pia Gattinger, et al.
Page
of 53